| 000 | 01742 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517040725.0 | ||
| 264 | 0 | _c20160502 | |
| 008 | 201605s 0 0 eng d | ||
| 022 | _a1878-1705 | ||
| 024 | 7 |
_a10.1016/j.intimp.2015.06.019 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWei, Mei-Juan | |
| 245 | 0 | 0 |
_aEfficacy of HBV-pulsed DCs in combination with entecavir in patients with chronic hepatitis B infection. _h[electronic resource] |
| 260 |
_bInternational immunopharmacology _cAug 2015 |
||
| 300 |
_a238-43 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCell- and Tissue-Based Therapy |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aDNA, Viral _xblood |
| 650 | 0 | 4 |
_aDendritic Cells _ximmunology |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGuanine _xanalogs & derivatives |
| 650 | 0 | 4 | _aHepatitis B e Antigens |
| 650 | 0 | 4 | _aHepatitis B virus |
| 650 | 0 | 4 |
_aHepatitis B, Chronic _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSeroconversion |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aPan, Xing-Nan | |
| 700 | 1 | _aWei, Kai-Peng | |
| 700 | 1 | _aLi, Xu-Hong | |
| 700 | 1 | _aLiu, Xiao-Long | |
| 700 | 1 | _aZhang, Xiao-Man | |
| 700 | 1 | _aJiang, Ya-Ling | |
| 700 | 1 | _aZhang, Chun-Yu | |
| 700 | 1 | _aShen, Jian-Kun | |
| 773 | 0 |
_tInternational immunopharmacology _gvol. 27 _gno. 2 _gp. 238-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.intimp.2015.06.019 _zAvailable from publisher's website |
| 999 |
_c25024155 _d25024155 |
||